Luye Pharma Announces U.S. FDA Approval of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for Treating Schizophrenia and Schizoaffective Disorder ...Middle East

PRINCETON, N.J., July 28, 2024 /PRNewswire/ -- Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sales of innovative medications, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's...

Hence then, the article about luye pharma announces u s fda approval of erzofri paliperidone palmitate extended release injectable suspension for treating schizophrenia and schizoaffective disorder was published today ( Sunday 28/07/2024 - 05:05 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Luye Pharma Announces U.S. FDA Approval of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for Treating Schizophrenia and Schizoaffective Disorder )

Also on site :

• ‘Free Bert’ Review: Bert Kreischer Strips Away the Shirtless Party Boy Persona, but Also the Laughs, in New Netflix Comedy
• ‘90s Alt-Rock Icon Announces First Show of the Year in California
• NYT Connections Sports Edition Today: Hints and Answers for Thursday, January 22, 2026